← Leaderboards
Steven Daniel Douglas
Children'S Hospital Of Philadelphia
$42,176,966
Attributed
$42,176,966
Total exposure
23
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.1M · FY2005–22$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$58,618,128 · 26
By mechanism
U01$29,272,138 · 7
P01$13,265,918 · 6
R01$10,142,795 · 3
UM1$3,098,056 · 1
P30$2,264,566 · 3
R21$445,550 · 1
Top collaborators
- Jay Rappaport3 shared
- Tracy Fischer1 shared
Most similar at Children'S Hospital Of Philadelphia
Same institution · by research overlap
- Avital Cnaan$7,481,273
- Bret J Rudy$5,647,039
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsSubstance PInfectionResearch PersonnelCellsMacrophageDesignProgramsAcquired Immunodeficiency SyndromeCollaborationsSubstance P ReceptorLeadershipAids/Hiv ProblemViralPhiladelphiaMonocyteClinical TrialsIn VitroLinkImmuneAprepitantPediatric HospitalsUniversitiesReceptor
Grant awards (102)
Core E: Laboratory and biobehavioral marker core$240,428
P30 · FY2022 · MH · contact PI
Core E: Laboratory and biobehavioral marker core$238,214
P30 · FY2021 · MH · contact PI
Core E: Laboratory and biobehavioral marker core$199,148
P30 · FY2020 · MH · contact PI
Core E: Laboratory and biobehavioral marker core$201,713
P30 · FY2019 · MH · contact PI
Core E: Laboratory and biobehavioral marker core$201,637
P30 · FY2018 · MH · contact PI
NeuroAIDS Therapeutics-Targeting Immune Polarization of Macrophages in CNS$1,070,697
P01 · FY2017 · MH
Project 3: Targeting Neurokinin 1 Receptor$244,532
P01 · FY2017 · MH · contact PI
Laboratory Biomarkers, Quantitative Pharmacology, Neuroimaging and Neurobeha$196,886
P30 · FY2017 · MH · contact PI
Immunoprophylaxis By Gene Transfer: Shortcut To An HIV Vaccine$1,147,087
R01 · FY2016 · AI · contact PI
NeuroAIDS Therapeutics-Targeting Immune Polarization of Macrophages in CNS$1,083,387
P01 · FY2016 · MH
Project 3: Targeting Neurokinin 1 Receptor$242,700
P01 · FY2016 · MH · contact PI
Laboratory Biomarkers, Quantitative Pharmacology, Neuroimaging and Neurobeha$199,504
P30 · FY2016 · MH · contact PI
Immunoprophylaxis By Gene Transfer: Shortcut To An HIV Vaccine$1,147,087
R01 · FY2015 · AI · contact PI
NeuroAIDS Therapeutics-Targeting Immune Polarization of Macrophages in CNS$1,042,975
P01 · FY2015 · MH
Adolescent Trials Unit at The Children's Hospital of Philadelphia$803,833
U01 · FY2015 · HD · contact PI
Project 3: Targeting Neurokinin 1 Receptor$279,146
P01 · FY2015 · MH · contact PI
Laboratory Biomarkers, Quantitative Pharmacology, Neuroimaging and Neurobeha$195,205
P30 · FY2015 · MH · contact PI
NeuroAIDS Therapeutics-Targeting Immune Polarization of Macrophages in CNS$1,110,500
P01 · FY2014 · MH
Adolescent Trials Unit at The Children's Hospital of Philadelphia$727,932
U01 · FY2014 · HD · contact PI
Project 3: Targeting Neurokinin 1 Receptor$351,220
P01 · FY2014 · MH · contact PI
CD163 in HIV Immunopathogenesis$209,375
R21 · FY2014 · AI · contact PI
Laboratory Biomarkers, Quantitative Pharmacology, Neuroimaging and Neurobeha$204,508
P30 · FY2014 · MH · contact PI
Philadelphia IMPAACT Clinical Trials Unit$46,445
UM1 · FY2014 · AI · contact PI
Philadelphia IMPAACT Clinical Trials Unit$1,129,111
UM1 · FY2013 · AI · contact PI
Anti-HIV Neuroimmunomodulatory Therapy with Neurokinin-1 (NK1-R) Antagonists$1,086,711
U01 · FY2013 · MH · contact PI
Adolescent Trials Unit at The Children's Hospital of Philadelphia$692,572
U01 · FY2013 · HD · contact PI
Project 5$300,817
U01 · FY2013 · MH · contact PI
CD163 in HIV Immunopathogenesis$236,175
R21 · FY2013 · AI · contact PI
Laboratory Biomarkers, Quantitative Pharmacology, Neuroimaging and Neurobeha$221,902
P30 · FY2013 · MH · contact PI
Project 2$196,554
U01 · FY2013 · MH · contact PI
Core A$158,053
U01 · FY2013 · MH · contact PI
Philadelphia IMPAACT Clinical Trials Unit$1,922,500
UM1 · FY2012 · AI · contact PI
Anti-HIV Neuroimmunomodulatory Therapy with Neurokinin-1 (NK1-R) Antagonists$1,123,370
U01 · FY2012 · MH · contact PI
Adolescent Trials Unit at The Children's Hospital of Philadelphia$711,150
U01 · FY2012 · HD · contact PI
Tachykinins Mononuclear Phagocytes and HIV-1 Infection$386,781
R01 · FY2012 · MH · contact PI
Project 5$328,121
U01 · FY2012 · MH · contact PI
Project 2$206,682
U01 · FY2012 · MH · contact PI
Core A$166,655
U01 · FY2012 · MH · contact PI
Philadelphia IMPAACT Clinical Trials Unit$1,838,701
U01 · FY2011 · AI · contact PI
Anti-HIV Neuroimmunomodulatory Therapy with Neurokinin-1 (NK1-R) Antagonists$1,125,714
U01 · FY2011 · MH · contact PI
Adolescent Trials Unit at The Children's Hospital of Philadelphia$708,634
U01 · FY2011 · HD · contact PI
Tachykinins Mononuclear Phagocytes and HIV-1 Infection$386,781
R01 · FY2011 · MH · contact PI
Project 5$328,590
U01 · FY2011 · MH · contact PI
Project 2$209,788
U01 · FY2011 · MH · contact PI
Core A$168,862
U01 · FY2011 · MH · contact PI
NEUROKININ-1 RECEPTOR EXPRESSION IN THE BRAINS OF SIV-INFECTED RHESUS MACAQUES$57,750
P51 · FY2011 · RR · contact PI
Philadelphia IMPAACT Clinical Trials Unit$2,087,680
U01 · FY2010 · AI · contact PI
Anti-HIV Neuroimmunomodulatory Therapy with Neurokinin-1 (NK1-R) Antagonists$1,138,312
U01 · FY2010 · MH · contact PI
Adolescent Medicine Trials Network for HIV/AIDS Interve*$739,565
U01 · FY2010 · HD · contact PI
Tachykinins Mononuclear Phagocytes and HIV-1 Infection$390,688
R01 · FY2010 · MH · contact PI
Project 5$327,917
U01 · FY2010 · MH · contact PI
Project 2$216,215
U01 · FY2010 · MH · contact PI
Core A$172,487
U01 · FY2010 · MH · contact PI
NEUROKININ-1 RECEPTOR EXPRESSION IN THE BRAINS OF SIV-INFECTED RHESUS MACAQUES$61,801
P51 · FY2010 · RR · contact PI
Philadelphia IMPAACT Clinical Trials Unit$2,052,385
U01 · FY2009 · AI · contact PI
Anti-HIV Neuroimmunomodulatory Therapy with Neurokinin-1 (NK1-R) Antagonists$1,166,337
U01 · FY2009 · MH · contact PI
Adolescent Medicine Trials Network for HIV/AIDS Interve*$725,279
U01 · FY2009 · HD · contact PI
Tachykinins Mononuclear Phagocytes and HIV-1 Infection$390,688
R01 · FY2009 · MH · contact PI
Project 5$353,983
U01 · FY2009 · MH · contact PI
Project 2$231,783
U01 · FY2009 · MH · contact PI
Core A$172,664
U01 · FY2009 · MH · contact PI
Philadelphia IMPAACT Clinical Trials Unit$1,674,252
U01 · FY2008 · AI · contact PI
Neurokinin-1R (SP Receptor) Antagonists for HIV Therapy$1,592,560
P01 · FY2008 · MH · contact PI
Adolescent Medicine Trials Network for HIV/AIDS Interve*$704,152
U01 · FY2008 · HD · contact PI
Tachykinins Mononuclear Phagocytes and HIV-1 Infection$451,478
R01 · FY2008 · MH · contact PI
Neurokinin-1R Antagonists-Cellular And Molecular Mechanisms$252,898
P01 · FY2008 · MH · contact PI
Core A$147,837
P01 · FY2008 · MH · contact PI
Philadelphia IMPAACT Clinical Trials Unit$1,641,630
U01 · FY2007 · AI · contact PI
Neurokinin-1R (SP Receptor) Antagonists for HIV Therapy$1,640,356
P01 · FY2007 · MH · contact PI
Tachykinins Mononuclear Phagocytes and HIV-1 Infection$559,348
R01 · FY2007 · MH · contact PI
Neurokinin-1R Antagonists-Cellular And Molecular Mechanisms$284,806
P01 · FY2007 · MH · contact PI
Neurokinin-1R (SP Receptor) Antagonists for HIV Therapy$1,659,482
P01 · FY2006 · MH · contact PI
Philadelphia Pediatric AIDS Clinical Trials Unit$717,352
U01 · FY2006 · AI · contact PI
Tachykinins Mononuclear Phagocytes and HIV-1 Infection$514,012
R01 · FY2006 · MH · contact PI
Neurokinin-1R Antagonists-Cellular And Molecular Mechanisms$262,297
P01 · FY2006 · MH · contact PI
Neurokinin-1R (SP Receptor) Antagonists for HIV Therapy$90,206
P01 · FY2006 · MH · contact PI
Neurokinin-1R (SP Receptor) Antagonists for HIV Therapy$1,510,555
P01 · FY2005 · MH
Philadelphia Pediatric AIDS Clinical Trials Unit$1,062,543
U01 · FY2005 · AI
Tachykinins Mononuclear Phagocytes and HIV-1 Infection$513,770
R01 · FY2005 · MH
Interaction of Human Immune Cells Alcohol &HIV$415,000
R01 · FY2005 · AA
Neurokinin-1R Antagonists-Cellular And Molecular Mechanisms$251,709
P01 · FY2005 · MH
Administrative$148,055
P01 · FY2005 · MH
Philadelphia Pediatric AIDS Clinical Trials Unit$1,023,391
U01 · FY2004 · AI
Tachykinins Mononuclear Phagocytes and HIV-1 Infection$501,528
R01 · FY2004 · MH
Interaction of Human Immune Cells Alcohol &HIV$415,000
R01 · FY2004 · AA
PACTG 265: VARICELLA VACCINE (VARIVAX) IN HIV-INFECTED CHILDREN$4,687
M01 · FY2004 · RR
PACTG 326: ALVAC HIV VACCINES AND AIDSVAX B/B IN CHILDREN BORN TO HIV MOTHERS$4,307
M01 · FY2004 · RR
Philadelphia Pediatric AIDS Clinical Trials Unit$1,062,458
U01 · FY2003 · AI
Tachykinins Mononuclear Phagocytes and HIV-1 Infection$460,826
R01 · FY2003 · MH
Interaction of Human Immune Cells Alcohol &HIV$415,000
R01 · FY2003 · AA
Philadelphia Pediatric AIDS Clinical Trials Unit$1,119,014
U01 · FY2002 · AI
Interaction of Human Immune Cells Alcohol &HIV$415,000
R01 · FY2002 · AA
TACHYKININS, MONONUCLEAR PHAGOCYTES AND HIV1 INFECTION$380,587
R01 · FY2002 · MH
Interaction of Human Immune Cells, Alcohol &HIV$10,625
R01 · FY2002 · AA
CORE--IMMUNOLOGY FACILITY$0
P30 · FY2002 · AI
TACHYKININS, MONONUCLEAR PHAGOCYTES AND HIV1 INFECTION$422,899
R01 · FY2001 · MH
Interaction of Human Immune Cells, Alcohol &HIV$385,800
R01 · FY2001 · AA
CORE--IMMUNOLOGY FACILITY$0
P30 · FY2001 · AI
CORE--IMMUNOLOGY FACILITY$0
P30 · FY2001 · AI
TACHYKININS, MONONUCLEAR PHAGOCYTES AND HIV1 INFECTION$432,810
R01 · FY2000 · MH
CORE--IMMUNOLOGY FACILITY$165,421
P30 · FY2000 · AI
ALTERNATIVE METHODOLOGIES FOR CD4 AND CD8 T LYPHOCCYTE DETERMINATIONS$560
M01 · FY2000 · RR